EyeGate Pharma Announces Positive Results in Second PRK Study

Go back to EyeGate Pharma Announces Positive Results in Second PRK Study
(NASDAQ: EYEG) Delayed: 34.51 +0.02 (0.06%)
Previous Close $34.49    52 Week High $5.09 
Open $34.51    52 Week Low $1.11 
Day High $34.51    P/E N/A 
Day Low $34.51    EPS $0.00 
Volume 260